Concepedia

Guillaume Lingas

GL

Statistics

Publications

24

Citations

6.7K

H-Index

19

Active since

2020

Affiliations

Inserm(Current)

Université Paris Cité

Infection, Anti-microbiens, Modélisation, Evolution

Hôpital Bichat-Claude-Bernard

Assistance Publique – Hôpitaux de Paris

Guillaume Lingas is an author at Inserm specializing in infectious diseases, sars-cov-2 infection, and life sciences.

ORCID

Publications per year

2020–2024

24

Publications

24

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

, , +14

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang, Paul Bastard, Zhiyong Liu et al. · Science · 2020 · 2.4K citations · Full text

, , +16

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

Nadège Néant, Guillaume Lingas, Quentin Le Hingrat et al. · Proceedings of the National Academy of Sciences · 2021 · 254 citations · Full text

, , +17

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

, , +15

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

Jean‐Sélim Driouich, Maxime Cochin, Guillaume Lingas et al. · Nature Communications · 2021 · 149 citations · Full text

, , +15

1–5 of 24